Buy One Get One free -Llimited Time Offer X
Combigan is a commercial drug that is prescribed in the form of Drops. Secondary and off-label uses of Combigan have also been mentioned below.
The correct dosage of Combigan depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Combigan include Eye Burning, Eye irritation, Stinging in the Eyes. While these are the most often observed Combigan side effects, there are can be others also. These have been listed below. Normally, these side effects of Combigan are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Combigan has a Mild effect for pregnant women and Unknown effect on lactating mothers. Warnings related to Combigan's effects on the liver, heart and kidney, if any, have been listed below.
Combigan can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Combigan in conditions like Heart Failure, Diabetes, COPD (Chronic Obstructive Pulmonary Disease). Some other conditions that can be affected by Combigan are listed in the contraindications section below.
Drug reaction of Combigan with other medicines has been reported. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Combigan is safe while driving, and is is addictive in nature.
Combigan is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Combigan safe for pregnant women?
Combigan has mild to no side effects in pregnant women.
Is the use of Combigan safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Combigan for breastfeeding women are not known.
What is the effect of Combigan on the Kidneys?
Combigan can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Combigan on the Liver?
Combigan may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Combigan on the Heart?
There may be an adverse effect on the heart after taking Combigan. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Combigan should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Combigan unless your doctor advises you to do so -
Is this Combigan habit forming or addictive?
Forming a habit of Combigan has not been reported.
Interaction between Food and Combigan
Taking Combigan with food does not harm your health.
Interaction between Alcohol and Combigan
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Combigan.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Istalol® (timolol maleate ophthalmic solution)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1401
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 153
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1405
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 154
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Alphagan® (brimonidine tartrate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Simbrinza™ (brinzolamide/brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Enidin® (brimonidine tartrate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Alphagan® P (brimonidine tartrate)